# Credit Acceptance Corp: financial statements, quarterly

CACC · Nasdaq · CIK 885550 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cacc.md) · [Financials](/companies/cacc/financials.md) · [Filings](/companies/cacc/filings.md) · [Insiders](/companies/cacc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cacc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [492 d](/filings/0000885550-26-000047.md) | [508](/filings/0000885550-25-000055.md) | [538](/filings/0000885550-25-000085.md) | [550](/filings/0000885550-25-000124.md) | [566 d](/filings/0000885550-26-000047.md) | [571](/filings/0000885550-26-000080.md) | [584](/filings/0000885550-26-000182.md) | [582](/filings/0000885550-26-000201.md) | [580 d](/filings/0000885550-26-000047.md) | [580](/filings/0000885550-26-000080.md) | [587](/filings/0000885550-26-000182.md) | [595](/filings/0000885550-26-000201.md) |
| Interest expense | $m | [78.8 d](/filings/0000885550-26-000047.md) | [92.5](/filings/0000885550-25-000055.md) | [105](/filings/0000885550-25-000085.md) | [111](/filings/0000885550-25-000124.md) | [111 d](/filings/0000885550-26-000047.md) | [115](/filings/0000885550-26-000080.md) | [118](/filings/0000885550-26-000182.md) | [116](/filings/0000885550-26-000201.md) | [114 d](/filings/0000885550-26-000047.md) | [108](/filings/0000885550-26-000080.md) | [107](/filings/0000885550-26-000182.md) | [107](/filings/0000885550-26-000201.md) |
| Income tax | $m | [22.8 d](/filings/0000885550-26-000047.md) | [22.1](/filings/0000885550-25-000055.md) | [(8.2)](/filings/0000885550-25-000085.md) | [27.7](/filings/0000885550-25-000124.md) | [40.0 d](/filings/0000885550-26-000047.md) | [35.4](/filings/0000885550-26-000080.md) | [30.4](/filings/0000885550-26-000182.md) | [40.7](/filings/0000885550-26-000201.md) | [35.0 d](/filings/0000885550-26-000047.md) | [39.2](/filings/0000885550-26-000080.md) | [32.7](/filings/0000885550-26-000182.md) | [(16.9)](/filings/0000885550-26-000201.md) |
| Net income | $m | [93.6 d](/filings/0000885550-26-000047.md) | [64.3](/filings/0000885550-25-000055.md) | [(47.1)](/filings/0000885550-25-000085.md) | [78.8](/filings/0000885550-25-000124.md) | [152 d](/filings/0000885550-26-000047.md) | [106](/filings/0000885550-26-000080.md) | [87.4](/filings/0000885550-26-000182.md) | [108](/filings/0000885550-26-000201.md) | [122 d](/filings/0000885550-26-000047.md) | [136](/filings/0000885550-26-000080.md) | [136](/filings/0000885550-26-000182.md) | [(56.6)](/filings/0000885550-26-000201.md) |
| Diluted EPS | $ per share | not reported | [5.08](/filings/0000885550-25-000055.md) | [(3.83)](/filings/0000885550-25-000085.md) | [6.35](/filings/0000885550-25-000124.md) | not reported | [8.66](/filings/0000885550-26-000080.md) | [7.42](/filings/0000885550-26-000182.md) | [9.43](/filings/0000885550-26-000201.md) | not reported | [12.40](/filings/0000885550-26-000080.md) | [12.66](/filings/0000885550-26-000182.md) | [(5.43)](/filings/0000885550-26-000201.md) |
| Basic EPS | $ per share | not reported | [5.15](/filings/0000885550-25-000055.md) | [(3.83)](/filings/0000885550-25-000085.md) | [6.42](/filings/0000885550-25-000124.md) | not reported | [8.79](/filings/0000885550-26-000080.md) | [7.55](/filings/0000885550-26-000182.md) | [9.62](/filings/0000885550-26-000201.md) | not reported | [12.64](/filings/0000885550-26-000080.md) | [12.97](/filings/0000885550-26-000182.md) | [(5.43)](/filings/0000885550-26-000201.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.2](/filings/0000885550-26-000047.md) | [8.4](/filings/0000885550-25-000055.md) | [8.3](/filings/0000885550-25-000085.md) | [160](/filings/0000885550-25-000124.md) | [344](/filings/0000885550-26-000201.md) | [529](/filings/0000885550-26-000080.md) | [70.0](/filings/0000885550-26-000182.md) | [15.9](/filings/0000885550-26-000201.md) | [22.8](/filings/0000885550-26-000201.md) | [25.7](/filings/0000885550-26-000080.md) | [1.4](/filings/0000885550-26-000182.md) | [1.3](/filings/0000885550-26-000201.md) |
| Total assets | $m | [7,610](/filings/0000885550-25-000012.md) | [8,097](/filings/0000885550-24-000069.md) | [8,255](/filings/0000885550-24-000092.md) | [8,683](/filings/0000885550-24-000119.md) | [8,855](/filings/0000885550-26-000047.md) | [9,258](/filings/0000885550-25-000055.md) | [8,725](/filings/0000885550-25-000085.md) | [8,641](/filings/0000885550-25-000124.md) | [8,632](/filings/0000885550-26-000201.md) | [8,695](/filings/0000885550-26-000080.md) | [8,623](/filings/0000885550-26-000182.md) | [8,878](/filings/0000885550-26-000201.md) |
| Total liabilities | $m | [5,857](/filings/0000885550-25-000012.md) | [6,445](/filings/0000885550-24-000069.md) | [6,701](/filings/0000885550-24-000092.md) | [7,037](/filings/0000885550-24-000119.md) | [7,105](/filings/0000885550-26-000047.md) | [7,547](/filings/0000885550-25-000055.md) | [7,170](/filings/0000885550-25-000085.md) | [7,062](/filings/0000885550-25-000124.md) | [7,108](/filings/0000885550-26-000201.md) | [7,181](/filings/0000885550-26-000080.md) | [7,034](/filings/0000885550-26-000182.md) | [7,489](/filings/0000885550-26-000201.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,754](/filings/0000885550-26-000047.md) | [1,652](/filings/0000885550-25-000085.md) | [1,555](/filings/0000885550-25-000124.md) | [1,647](/filings/0000885550-25-000124.md) | [1,750](/filings/0000885550-26-000201.md) | [1,711](/filings/0000885550-26-000182.md) | [1,555](/filings/0000885550-26-000201.md) | [1,579](/filings/0000885550-26-000201.md) | [1,524](/filings/0000885550-26-000201.md) | [1,514](/filings/0000885550-26-000182.md) | [1,589](/filings/0000885550-26-000201.md) | [1,389](/filings/0000885550-26-000201.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [311 d](/filings/0000885550-26-000047.md) | [310](/filings/0000885550-25-000055.md) | [204 d](/filings/0000885550-25-000085.md) | [318 d](/filings/0000885550-25-000124.md) | [306 d](/filings/0000885550-26-000047.md) | [346](/filings/0000885550-26-000080.md) | [140 d](/filings/0000885550-26-000182.md) | [299 d](/filings/0000885550-26-000201.md) | [269 d](/filings/0000885550-26-000047.md) | [347](/filings/0000885550-26-000080.md) | [310 d](/filings/0000885550-26-000182.md) | [336 d](/filings/0000885550-26-000201.md) |
| Capital expenditure | $m | [1.7 d](/filings/0000885550-26-000047.md) | [0.3](/filings/0000885550-25-000055.md) | [0.4 d](/filings/0000885550-25-000085.md) | [0.4 d](/filings/0000885550-25-000124.md) | [0.7 d](/filings/0000885550-26-000047.md) | [0.3](/filings/0000885550-26-000080.md) | [0.3 d](/filings/0000885550-26-000182.md) | [0.6 d](/filings/0000885550-26-000201.md) | [0.4 d](/filings/0000885550-26-000047.md) | [1.3](/filings/0000885550-26-000080.md) | [1.6 d](/filings/0000885550-26-000182.md) | [1.4 d](/filings/0000885550-26-000201.md) |
| Share repurchases | $m | [53.6 d](/filings/0000885550-26-000047.md) | [191](/filings/0000885550-25-000055.md) | [60.8 d](/filings/0000885550-25-000085.md) | [0.0 d](/filings/0000885550-25-000124.md) | [61.4 d](/filings/0000885550-26-000047.md) | [164](/filings/0000885550-26-000080.md) | [262 d](/filings/0000885550-26-000182.md) | [107 d](/filings/0000885550-26-000201.md) | [191 d](/filings/0000885550-26-000047.md) | [179](/filings/0000885550-26-000080.md) | [141 d](/filings/0000885550-26-000182.md) | [162 d](/filings/0000885550-26-000201.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.1](/filings/0000885550-24-000069.md) | [13.1](/filings/0000885550-24-000092.md) | [13.0](/filings/0000885550-24-000119.md) | [12.6](/filings/0000885550-25-000055.md) | [12.3](/filings/0000885550-25-000085.md) | [12.4](/filings/0000885550-25-000124.md) | [12.3](/filings/0000885550-26-000080.md) | [11.8](/filings/0000885550-26-000182.md) | [11.5](/filings/0000885550-26-000201.md) | [11.0](/filings/0000885550-26-000080.md) | [10.7](/filings/0000885550-26-000182.md) | [10.4](/filings/0000885550-26-000201.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,137,465 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0000885550-26-000201.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:40 ET. No prices; not investment advice.